PC14586
pmv pharmaceuticals
['sclc', 'lcsm,(-blcsm)']
dr ecaterina elena dumbrava presents results of pynnacle trial for small mol, oral first-in-class targeted therapy for p53y220c. results showed rapid and sustained part response for 9+ months in sclc. small sample size, more testing needed. #asco22 #sclc #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.